Interpretation of Human Epidermal Growth Factor Receptor 2 (HER2) In Situ Hybridization Assays Using 2013 Update of American Society of Clinical Oncology/College of American Pathologists HER2 Guidelines

被引：14
|
作者：
Bhargava, Rohit [1 ]
Dabbs, David J. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Magee Womens Hosp, Pittsburgh, PA 15260 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 17期
关键词：
RECOMMENDATIONS; TRASTUZUMAB;
D O I：
10.1200/JCO.2013.53.9213
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1855 / 1855
页数：1
相关论文
共 50 条
  • [1] Impact of the 2013 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing of invasive breast carcinoma: a focus on tumours assessed as 'equivocal' for HER2 gene amplification by fluorescence in-situ hybridization
    Bethune, Gillian C.
    van Zanten, Daniel Veldhuijzen
    MacIntosh, Rebecca F.
    Rayson, Daniel
    Younis, Tallal
    Thompson, Kara
    Barnes, Penny J.
    HISTOPATHOLOGY, 2015, 67 (06) : 880 - 887
  • [2] Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancers
    Kamaljeet Singh
    Umadevi Tantravahi
    Michele M. Lomme
    Terese Pasquariello
    Margaret Steinhoff
    C. James Sung
    Breast Cancer Research and Treatment, 2016, 157 : 405 - 411
  • [3] Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancers
    Singh, Kamaljeet
    Tantravahi, Umadevi
    Lomme, Michele M.
    Pasquariello, Terese
    Steinhoff, Margaret
    Sung, C. James
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (03) : 405 - 411
  • [4] Guideline Summary: American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor HER2 Testing in Breast Cancer
    不详
    JOURNAL OF ONCOLOGY PRACTICE, 2007, 3 (01) : 48 - 50
  • [5] American Society of Clinical Oncology/College of American Pathologists 2018 Focused Update of Breast Cancer HER2 FISH Testing Guidelines
    Lin, Leo
    Sirohi, Deepika
    Coleman, Joshua F.
    Gulbahce, H. Evin
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 (04) : 479 - 485
  • [6] Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer
    Shah, Sejal S.
    Ketterling, Rhett P.
    Goetz, Matthew P.
    Ingle, James N.
    Reynolds, Carol A.
    Perez, Edith A.
    Chen, Beiyun
    HUMAN PATHOLOGY, 2010, 41 (01) : 103 - 106
  • [7] Assessing the New American Society of Clinical Oncology/College of American Pathologists Guidelines for HER2 Testing by Fluorescence In Situ Hybridization: Experience of an Academic Consultation Practice
    Press, Michael F.
    Villalobos, Ivonne
    Santiago, Angela
    Guzman, Roberta
    Cervantes, Monica
    Gasparyan, Armen
    Campeau, Anaamika
    Ma, Yanling
    Tsao-Wei, Denice D.
    Groshen, Susan
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (11) : 1250 - 1258
  • [8] Impact of 2013 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2 Fluorescent In Situ Hybridization Testing in Breast Cancers Experience From a National Reference Laboratory
    Gulbahce, H. Evin
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 148 (04) : 308 - 313
  • [9] Human Epidermal Growth Factor Receptor 2 Testing by Fluorescent In Situ Hybridization: Positive or Negative? American Society of Clinical Oncology/College of American Pathologists Guidelines 2007, 2013, and 2018
    Murray, Ciara
    D'Arcy, Clare
    Gullo, Giuseppe
    Flanagan, Louise
    Quinn, Cecily M.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2019, 143 (04) : 412 - 413
  • [10] Reappraisal of Human Epidermal Growth Factor Receptor 2 (HER2) in High-grade Urothelial Carcinoma (HGUCa) Based on American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) Clinical Practice Guidelines, 2018
    Mohanty, Sambit
    Tiwari, Ankit
    Baisakh, Manas
    Naik, Subhasini
    Chawla, Preeti
    Das, Subodh
    Pradhan, Manas
    Satapathy, Kali
    Dhillon, Jasreman
    MODERN PATHOLOGY, 2019, 32
12345